Semicarbazone EGA Inhibits Uptake of Diphtheria Toxin into Human Cells and Protects Cells from Intoxication
AbstractDiphtheria toxin is a single-chain protein toxin that invades human cells by receptor-mediated endocytosis. In acidic endosomes, its translocation domain inserts into endosomal membranes and facilitates the transport of the catalytic domain (DTA) from endosomal lumen into the host cell cytosol. Here, DTA ADP-ribosylates elongation factor 2 inhibits protein synthesis and leads to cell death. The compound 4-bromobenzaldehyde N-(2,6-dimethylphenyl)semicarbazone (EGA) has been previously shown to protect cells from various bacterial protein toxins which deliver their enzymatic subunits from acidic endosomes to the cytosol, including Bacillus anthracis lethal toxin and the binary clostridial actin ADP-ribosylating toxins C2, iota and Clostridium difficile binary toxin (CDT). Here, we demonstrate that EGA also protects human cells from diphtheria toxin by inhibiting the pH-dependent translocation of DTA across cell membranes. The results suggest that EGA might serve for treatment and/or prevention of the severe disease diphtheria. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Schnell, L.; Mittler, A.-K.; Mattarei, A.; Tehran, D.A.; Montecucco, C.; Barth, H. Semicarbazone EGA Inhibits Uptake of Diphtheria Toxin into Human Cells and Protects Cells from Intoxication. Toxins 2016, 8, 221.
Schnell L, Mittler A-K, Mattarei A, Tehran DA, Montecucco C, Barth H. Semicarbazone EGA Inhibits Uptake of Diphtheria Toxin into Human Cells and Protects Cells from Intoxication. Toxins. 2016; 8(7):221.Chicago/Turabian Style
Schnell, Leonie; Mittler, Ann-Katrin; Mattarei, Andrea; Tehran, Domenico A.; Montecucco, Cesare; Barth, Holger. 2016. "Semicarbazone EGA Inhibits Uptake of Diphtheria Toxin into Human Cells and Protects Cells from Intoxication." Toxins 8, no. 7: 221.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.